title: Blood tests for asbestos-related mesothelioma.
abstract: Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of the tumor may be described as 30-40 years, and the prognosis is dismal. Recently, serum markers for the diagnosis of mesothelioma have been reported as candidates. In this paper, we mini-reviewed the potential utility of ELISA systems as serum diagnostic markers for asbestos-related mesothelioma.
authors.affiliation: Immuno-Biological Laboratories Co., Ltd., Fujioka-Shi, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Maeda
authors.forename: Okio
authors.initials: O
authors.lastname: Hino
mesh_terms: D001194:Asbestos / Q000633:toxicity*; D014408:Biomarkers, Tumor / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D002273:Carcinogens / Q000633:toxicity*; D004797:Enzyme-Linked Immunosorbent Assay; D058851:GPI-Linked Proteins; D006801:Humans; D008562:Membrane Glycoproteins / Q000097:blood*; D000090204:Mesothelin; D008654:Mesothelioma / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D015513:Oncogene Proteins / Q000097:blood*; D010997:Pleural Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000209:etiology
chemical_list: D014408:Biomarkers, Tumor; D001798:Blood Proteins; D002273:Carcinogens; C413325:Erc protein, human; D058851:GPI-Linked Proteins; D008562:Membrane Glycoproteins; D015513:Oncogene Proteins; D001194:Asbestos; D000090204:Mesothelin